Evidence map›Paper›PMID 35147051›Full record

ArticleInfectious diseases (London, England)2022

Trajectory of anti-SARS-COV-2 IgG antibodies from onset of symptoms to 6 months in a cohort of Pakistani patients.

Maria Mehmood, Haleema Usman Khan, Muhammad Ihtesham Khan, Ishaq Khan, Rajaa Mohammad Al-Raddadi, Steve Harakeh, Yasar Mehmood Yousafzai

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in Infectious diseases (London, England), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Maria MehmoodDepartment of Pathology, Khyber Medical College, Peshawar, Pakistan.ORCID 0000-0002-1673-1954
Haleema Usman KhanInstitute of Pathology and Diagnostic Medicine, Khyber Medical University, Peshawar, Pakistan.ORCID 0000-0003-3342-7177
Muhammad Ihtesham KhanDepartment of Pathology, Khyber Medical College, Peshawar, Pakistan.
Ishaq KhanInstitute of Basic Medical Sciences, Khyber Medical University, Peshawar, Pakistan.
Rajaa Mohammad Al-RaddadiCommunity Medicine Department, King Abdulaziz University, Jeddah, Saudi Arabia.
Steve HarakehSpecial Infectious Agents Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia.
Yasar Mehmood YousafzaiInstitute of Pathology and Diagnostic Medicine, Khyber Medical University, Peshawar, Pakistan.ORCID 0000-0002-3479-6153

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19Antibodies, ViralCohort StudiesHumansImmunoglobulin GPakistanAntibodies, ViralImmunoglobulin G

Identifiers

PMID35147051

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.